Skip to main content
SpringerLink
Log in

Preclinical Assessment of Novel Therapeutics on the Cough Reflex: Cannabinoid Agonists as Potential Antitussives

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Cough, a reflex defense mechanism, is a common symptom of many airway inflammatory diseases. At present there are no satisfactory treatments for cough that have an acceptable side effect profile. Recent data have described the inhibitory effect of selective cannabinoid CB2 receptor agonists on sensory nerve activity in vitro and the cough reflex in a guinea pig model. CB2 receptor expression is limited in the central nervous system (CNS) and hence the development of selective agonists may provide a new therapeutic strategy for treatment of cough devoid of the CNS-mediated side effects that are normally associated with nonselective cannabinoid agonists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Widdicombe JG (1999) Advances in understanding and treatment of cough. Monaldi Arch Chest Dis 54:275–279

    PubMed  CAS  Google Scholar 

  2. Shroeder K, Fahey T (2002) Systematic review of randomised controlled trials of over the counter cough medicines for acute cough in adults. BMJ 324:1–6

    Google Scholar 

  3. Karlsson JA, Fuller RW (1999) Pharmacological regulation of the cough reflex – from experimental models to antitussive effects in man. Pulm Pharmacol Ther 12:215–228

    Article  PubMed  CAS  Google Scholar 

  4. Moreaux B, Beerens D, Gustin P (1999) Development of a cough induction test in pigs: effects of SR 48968 and enalapril. J Vet Pharmacol Ther 22:387–389

    Article  PubMed  CAS  Google Scholar 

  5. Forsberg K, Karlsson JA, Theodorsen E, Lundberg JM, Persson CGA (1988) Cough and bronchoconstriction mediated by capsaicin-sensitive sensory neurons in guinea pigs. Pulm Pharmacol 1:33–39

    Article  PubMed  CAS  Google Scholar 

  6. Fox AJ, Barnes PJ, Urban L, Dray A (1993) An in vivo study of the properties of single vagal afferents innervating guinea pig airways. J Physiol 469:21–35

    PubMed  CAS  Google Scholar 

  7. Fox AJ (1996) Modulation of cough and airway sensory fibres. Pulm Pharmacol 9:335–342

    Article  PubMed  CAS  Google Scholar 

  8. Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, Barnes PJ (1996) Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough. Nat Med 2:814–817

    Article  PubMed  CAS  Google Scholar 

  9. Fox AJ, Barnes PJ, Venkatesan P, Belvisi MG (1997) Activation of large conductance potassium channels inhibits the afferent and efferent function of airway sensory nerves in the guinea pig. J Clin Invest 99:513–519

    Article  PubMed  CAS  Google Scholar 

  10. Lalloo UG, Fox AJ, Belvisi M, Chung K, Barnes PJ (1995) Capsazepine inhibits cough induced by capsaicin and citric acid but not by hypertonic saline in guinea pigs. J Appl Physiol 79:1082–1087

    PubMed  CAS  Google Scholar 

  11. Trevisani M, Milan A, Gatti R, Zanasi A, Harrison S, Fontana G, Morice AH, Geppetti P (2004) Antitussive activity of iodo-resiniferatoxin in guinea pigs. Thorax 59(9):769–772

    Article  PubMed  CAS  Google Scholar 

  12. Liu Q, Fujimura M, Tachibana H, Myou S, Kasahara K, Yasui M (2001) Characterization of increased cough sensitivity after antigen challenge in guinea pigs. Clin Exp Allergy 31(3):474–484

    Article  PubMed  CAS  Google Scholar 

  13. Oribe Y, Fujimura M, Kita T, Katayama N, Nishitsuji M, Hara J, Myou S, Nakao S (2005) Attenuating effect of H+K+ATPase inhibitors on airway cough hypersensitivity induced by allergic airway inflammation in guinea-pigs. Clin Exp Allergy 35(3):262–267

    Article  PubMed  CAS  Google Scholar 

  14. Lewis CA, Ambrose C, Banner K, Battram C, Butler K, Giddings J, Mok J, Nasra J, Winny C, Poll C (2007) Animal models of cough: literature review and presentation of a novel cigarette smoke-enhanced cough model in the guinea-pig. Pulm Pharmacol Ther 20(4):325–333

    Article  PubMed  CAS  Google Scholar 

  15. Nasra J, Birrell MA, Poll C, Lewis CA, Belvisi MG (2007) Distinct patterns of response to tussive agents in a guinea-pig model of cough: effect of cigarette smoke exposure. Am J Respir Crit Care Med 41:A667

    Google Scholar 

  16. Porter AC, Felder CC (2001) The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol Ther 90:45–60

    Article  PubMed  CAS  Google Scholar 

  17. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561–564

    Article  PubMed  CAS  Google Scholar 

  18. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterisation of a peripheral receptor for cannabinoids. Nature 365:61–65

    Article  PubMed  CAS  Google Scholar 

  19. Buckley NE, McCoy KL, Mezey E, Bonner T, Zimmer A, Felder C, Glass M, Zimmer A (2000) Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoiod CB2 receptor. Eur J Parmacol 396:141–149

    Article  CAS  Google Scholar 

  20. Griffin G, Fernando SR, Ross RA, McKay NG, Ashford MLJ, Shire D, Huffman JW, Yu S, Lainton JAH, Pertwee RG (1997) Evidence for the presence of CB2 like cannabinoid receptors on peripheral nerve terminals. Eur J Pharmacol 339:53–61

    Article  PubMed  CAS  Google Scholar 

  21. Galiegue S, Mary S, Marchland J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54–61

    Article  PubMed  CAS  Google Scholar 

  22. Richardson JD, Aanonsen L, Hargreaves KM (1998) Antihyperalgesic effects of spinal cannabinoids. Eur J Pharmacol 345:145–153

    Article  PubMed  CAS  Google Scholar 

  23. Clayton N, Marshall FH, Bountra C, O’Shaughnessy (2002) CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain 96:253–260

  24. Malan TP, Ibrahim MM, Vanderah TW, Makriyannis A, Porreca F (2002) Inhibition of pain responses by activation of CB2 cannabinoid receptors. Chem Physics Lipids 121:191–200

    Article  CAS  Google Scholar 

  25. Patel HJ, Birrell MA, Crispino N, Hele DJ, Venkatesan P, Barnes PJ, Yacoub MH, Belvisi MG (2003) Inhibition of guinea pig and human sensory nerve activity and the cough reflex in guinea pigs by cannabinoid (CB2) receptor activation. Br J Pharmacol 140:261–268

    Article  PubMed  CAS  Google Scholar 

  26. Calignano A, Katona I, Desarnaud F, Giuffrida A, La Rana G, Mackie K, Freund TF, Piomelli D (2000) Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature 408:96–101

    Article  PubMed  CAS  Google Scholar 

  27. Morita K, Kamei J (2003) Antitussive activity of WIN 55212-2, a cannabinoid receptor agonist. Eur J Pharmacol 427:269–272

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Respiratory Pharmacology Group, National Heart & Lung Institute, NHLI, Faculty of Medicine, Imperial College London, Guy Scadding Building, Dovehouse Street, London, SW3 6LY, UK

    Maria G. Belvisi

Authors
  1. Maria G. Belvisi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria G. Belvisi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Belvisi, M.G. Preclinical Assessment of Novel Therapeutics on the Cough Reflex: Cannabinoid Agonists as Potential Antitussives. Lung 186 (Suppl 1), 66–69 (2008). https://doi.org/10.1007/s00408-007-9028-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-007-9028-8

Keywords

Search

Navigation